Akumin Inc. (AKU)
Akumin Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Plantation, FL, US. The stock last traded at $0.29, down 17.87% on the session, giving a market capitalisation of $26.3M. On trailing twelve-month figures it carries a trailing P/E of -0.17, a net margin of -20.2%. Its beta of 0.45 implies it has historically moved less than the broad market.
Akumin Inc. specializes in delivering outpatient diagnostic imaging solutions across the United States. Its operations are divided into two main divisions: Radiology and Oncology. Through a network of roughly 200 imaging centers, which it either owns or manages, Akumin delivers a wide array of medical imaging modalities. These include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and various other diagnostic or interventional radiology procedures. The company extends its outpatient radiology and oncology services and comprehensive solutions to approximately 1,000 hospitals and healthcare systems spanning 46 states. Established in 2015, Akumin Inc. maintains its corporate headquarters in Plantation, Florida.
Akumin Inc. is most often compared with the following Healthcare names: